Market Insight - EBM turning know-how into action
This article was originally published in Scrip
Executive Summary
The shift towards evidence-based medicine is a welcome development, with companies already using innovative approaches to support more robust decision-making, writes Dr Richard Gliklich. Fail to address some of the industry's outdated silo structures, however, and some stakeholders will be left wanting.